Hantech Bio-Technology Co (ROCO:1294) EBITDA Margin %: 26.70% (As of Dec. 2025) — Near Median


ROCO:1294 Hantech Bio-Technology Co Ltd ROCO:1294
74 GF Score
Price NT$78.80
GF Value NT$90.14
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Hantech Bio-Technology Co EBITDA Margin %?

Hantech Bio-Technology Co ROCO:1294 -0.13% 74 EBITDA Margin % is 26.70% as of Dec. 2025, which is 3% below its 10-year median of 27.51. GuruFocus rates ROCO:1294 with a GF Score™ of 74/100 and a GF Value™ of NT$90.14 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 1,949 Consumer Packaged Goods companies, Hantech Bio-Technology Co ranks better than 91.84% on this metric.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Hantech Bio-Technology Co's EBITDA for the three months ended in Dec. 2025 was NT$57.1 Mil. Hantech Bio-Technology Co's Revenue for the three months ended in Dec. 2025 was NT$213.7 Mil. Therefore, Hantech Bio-Technology Co's EBITDA margin for the quarter that ended in Dec. 2025 was 26.70%.


Hantech Bio-Technology Co  (ROCO:1294) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Hantech Bio-Technology Co EBITDA Margin % Related Terms


Hantech Bio-Technology Co EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Hantech Bio-Technology Co's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hantech Bio-Technology Co EBITDA Margin % Chart

Hantech Bio-Technology Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBITDA Margin %
Get a 7-Day Free Trial 24.42 25.96 33.21 31.01 27.51

Hantech Bio-Technology Co Quarterly Data
Dec19 Dec20 Dec21 Jun22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 29.85 29.59 29.17 24.88 26.70

ROCO:1294 vs KHC, GIS: EBITDA Margin % Comparison

For the Packaged Foods subindustry, Hantech Bio-Technology Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hantech Bio-Technology Co EBITDA Margin % vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Hantech Bio-Technology Co's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Hantech Bio-Technology Co's EBITDA Margin % falls into.


ROCO:1294
74GF Score
Hantech Bio-Technology Co Ltd ROCO:1294
EBITDA Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hantech Bio-Technology Co EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Hantech Bio-Technology Co's EBITDA Margin % for the fiscal year that ended in Dec. 2025 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=214.159/778.543
=27.51 %

Hantech Bio-Technology Co's EBITDA Margin % for the quarter that ended in Dec. 2025 is calculated as

EBITDA Margin %=EBITDA (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=57.063/213.727
=26.70 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 26.70% mean?
Hantech Bio-Technology Co (ROCO:1294) has a EBITDA Margin % of 26.70% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Hantech Bio-Technology Co and its competitors. This is near median its historical median of 27.51. Over the past decade, Hantech Bio-Technology Co's EBITDA Margin % has ranged from 19.14 to 33.21. According to the industry distribution chart, Hantech Bio-Technology Co ranks #159 out of 1949 companies in the Consumer Packaged Goods industry, placing it in the top 8.2%.
Is Hantech Bio-Technology Co's EBITDA Margin % too high?
Hantech Bio-Technology Co's current EBITDA Margin % of 26.70% is near median its 10-year median of 27.51. Over the past 10 years, this metric has ranged from a low of 19.14 to a high of 33.21. The Consumer Packaged Goods industry median EBITDA Margin % is 8.97. Hantech Bio-Technology Co's value of 26.70% is 197.7% above this industry median. Based on the distribution chart, Hantech Bio-Technology Co ranks #159 out of 1949 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, Hantech Bio-Technology Co has a GF Score™ of 74/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Hantech Bio-Technology Co's EBITDA Margin % compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Hantech Bio-Technology Co ranks #159 out of 1949 companies for EBITDA Margin %. This places Hantech Bio-Technology Co in the top 8% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 8.97. Hantech Bio-Technology Co's value of 26.70% is 197.7% above this benchmark. Historically, Hantech Bio-Technology Co's own EBITDA Margin % has ranged from 19.14 to 33.21 over the past decade. While the company's 10-year median is 27.51 vs. the industry median of 8.97, Hantech Bio-Technology Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Consumer Packaged Goods company?
The median EBITDA Margin % among Consumer Packaged Goods companies is 8.97, based on 1,949 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hantech Bio-Technology Co's current EBITDA Margin % of 26.70% is 197.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Hantech Bio-Technology Co and its competitors. For the Consumer Packaged Goods industry, the median EBITDA Margin % is 8.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hantech Bio-Technology Co's current EBITDA Margin % is 26.70%, which is near median its own 10-year median of 27.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hantech Bio-Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Hantech Bio-Technology Co (ROCO:1294) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$90.14, compared to a current price of NT$78.80 — trading 12.6% below its estimated fair value. The current EBITDA Margin % is 26.70%, which is near median its 10-year median of 27.51 and 197.7% above the Consumer Packaged Goods industry median of 8.97. Hantech Bio-Technology Co's overall GF Score™ is 74/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Hantech Bio-Technology Co (ROCO:1294), the current EBITDA Margin % is 26.70% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hantech Bio-Technology Co (ROCO:1294) Overvalued in 2026?

Based on GuruFocus' analysis, Hantech Bio-Technology Co stock appears to be undervalued. The current stock price of NT$78.80 is trading 12.6% below its estimated GF Value™ of NT$90.14. GuruFocus considers Hantech Bio-Technology Co to be Modestly Undervalued.

Key valuation signals for ROCO:1294:

  • EBITDA Margin %: 26.70% (near median its 10-year median of 27.51)
  • GF Value™: NT$90.14 vs. price of NT$78.80 (12.6% below fair value)
  • GF Score™: 74/100 with 4 warning signs
  • Industry Position: 197.7% above the Consumer Packaged Goods median (#159 of 1949)

No single metric tells the full story. See the ROCO:1294 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Hantech Bio-Technology Co Business Description

Address No. 101, Gongye Road, Xihu Township, Changhua, TWN, 514
Hantech Bio-Technology Co Ltd mainly engaged in the manufacture, trading, and agency of biotech foods, health foods, and Traditional Chinese Medicine skincare and beauty products.
74GF Score

Get the complete analysis for ROCO:1294

EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$78.80
Price
NT$90.14
GF Value